Just Say No…to the Nocebo Effect

Inflamm Bowel Dis. 2020 Apr 11;26(5):669. doi: 10.1093/ibd/izaa021.

Authors

Leah Rossmann¹, Raymond K Cross²

Affiliations

¹ Department of Pharmacy, Division of Ambulatory Pharmacy, University of Maryland Medical Center, Baltimore, Maryland, USA.
² Department of Medicine, Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

PMID: 32031637
DOI: 10.1093/ibd/izaa021

No abstract available

Keywords: biosimilar; inflammatory bowel disease; nocebo effect.

Publication types

Editorial

MeSH terms

Biosimilar Pharmaceuticals / therapeutic use*
Drug Substitution*
Humans
Infliximab / therapeutic use
Nocebo Effect*
United States

Substances

Biosimilar Pharmaceuticals
Infliximab